• UCLA Health
  • myUCLAhealth
  • School of Medicine
Radiation Oncology UCLA

UCLA Radiation Oncology

Radiation Oncology UCLA
  • About Us
    • Chair's Welcome
    • Request an Appointment
    • Refer a Patient
    • Contact Us
    • How You Can Help
  • Our Team
  • Patients & Treatments
    • First Visit for Patients
    • Patient Education Film Library
    • FAQs
    • Patient Stories
    • Testimonials
    • Treatments
    • Resources / Links
    • Clinical Trials
    • Request an Appointment
    • Health Plans
    • Contact Us
  • Research & Technologies
    • Innovation & Technology
    • Cutting-Edge Devices
    • Division of Molecular and Cellular Oncology
    • Medical Physics Research
    • Research Labs
    • Scholarly Activity
    • Translational Research
    • Clinical Trials
    • PSMA Risk Calculator
  • Education & Training
    • Welcome and Overview
    • Residency and Fellowship Recruitment
    • Medical Residency
    • Podcast - At The Beam
    • Residents
    • Medical Physics Residency Program
    • Medical Student Rotation
    • Brachytherapy Fellowship
    • Medical Student Preceptorship Program
    • BioMedical Physics Graduate Program
  • News & Events
    • Conferences & Courses
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Radiation Oncology

Residents

  1. Home
  2. Education & Training
  3. Residents

Residents

Jie-Deng Photo

Jie Deng, MD, PhD

Dr. Jie Deng is from Clearwater, Florida and received her Bachelor's degree in Chemistry from the University of Florida. Her interest in studying cancer immunotherapy first stemmed from internships at the National Institutes of Health which led her to pursue MD/PhD training at Dartmouth Medical School. Her PhD research was focused on the transcriptional regulation of immune checkpoints, in particular of VISTA, by the tumor microenvironment and using these insights to inform strategic combinations of immunotherapy for cancer. Upon the completion of her MD/PhD, Dr. Deng spent a year in Chicago for her transitional year internship at Resurrection Medication Center, where she served as Chief Intern. At UCLA, she was selected to participate in the American Board of Radiology Holman Research Pathway, a specialized training mechanism designed for physician scientists. Under this Pathway, she has continued her post-doctoral training in tumor immunotherapy under the mentorship of Dr. Anusha Kalbasi investigating a novel therapeutic approach with intratumoral immunotherapy to reprogram radiation-associated myeloid cells in sarcoma, which is supported by a Jonsson Comprehensive Cancer Center Fellowship Award. Additionally, Dr. Deng has been pursuing clinical trial design and collaboration with industry.
Facebook Twitter Instagram Youtube LinkedIn
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 310-825-9775
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap